by Genomics Market size is expected to grow Usd 72.13 bn by 2030 at a CAGR of 13.65% over the forecast period 2021 – 2030.
A new study on the global Genomics market has been published by Precedence Research. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global Genomics market. The study offers valuable information about the global Genomics market to illustrate how the market would grow during the forecast period 2021-2030. The report provides the value and volume of the global Genomics market for the period 2021–2030, considering 2019 as the base year and 2030 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.
Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global Genomics market during the forecast period.
Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1204
An extensive analysis on business strategies of leading market players is also featured in study on the global Genomics market. This can help readers understand principal factors to foresee growth in the global Genomics market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.
The report also delves into the competition landscape of the global Genomics market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.
Key Players
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Oxford Nanopore Technologies
- QIAGEN N.V.
- BGI
- Eurofins Scientific
- GE Healthcare
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd.
- Others
Key Questions Answered in Genomics Market Study
– What are the key factors influencing the Genomics market in each region?
– What will be the CAGR of the global Genomics market between 2017 and 2030?
– What is the future scope and changing trends in technologies in the global Genomics market?
– Which factors will impede the growth of the global Genomics market during the forecast period?
– Which are the leading companies in the global Genomics market?
– Which region is set to expand at the fastest CAGR during the forecast period?
– What is the volume (Units) of different Genomics across all regions during the forecast period?
– Which segment will have the highest revenue globally in 2030 and which segment will expand at the fastest CAGR during the forecast period?
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1204
Research Methodology
A unique research methodology has been utilized by precedence research to conduct a comprehensive research on the growth of the global Genomics market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global Genomics market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from Genomics industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making precedence research estimates on the future prospects of the global market more reliable and accurate.
Segmentation
By Product and Services
- Consumables
- Systems and software
- Services Equipment
By Technology
- PCR (polymerase chain reaction)
- Sequencing
- Microarray
- Nucleic acid extraction and purification
- Other technologies (branched DNA analysis, single-cell genomics analysis, and flow cytometry)
By Application
- Drug discovery and development
- Diagnostics
- Precision medicine
- Agriculture and animal research
- Other applications
By End-Users
- Hospitals & clinics
- Research centers and academic & government institutes
- Pharmaceutical & biotechnology companies
- Other end users
By Regional Outlook
- North America
- S.
- Canada
- Europe
- K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- Southeast Asia
- Middle East and Africa
- GCC
- North Africa
- South Africa
- Rest of MEA
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Genomics Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Genomics Market
5.1. Covid-19: Genomics Industry Impact
5.2. Genomics Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and GenomicsOpportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Genomics Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Genomics Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2
Chapter 7. Global Genomics Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Genomics Market Revenue by Market Players (2015-2020)
7.1.1.2. Genomics Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Genomics Market, By Product Type
8.1. Genomics Market, by Component, 2016-2027
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Systems and software
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Services Equipment
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Genomics Market, By Application
9.1. Genomics Market, by Application, 2016-2027
9.1.1. Sequencing
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Microarray
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. PCR (polymerase chain reaction)
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Nucleic acid extraction and purification
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Genomics Market, By End-user
10.1. Genomics Market, by End-user, 2016-2027
10.1.1. Diagnostics
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Drug discovery and development
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Precision medicine
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Agriculture and animal research
10.1.5. Other applications
Chapter 11. Global GenomicsMarket, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2016-2027)
11.1.2. Market Revenue Forecast by Application (2016-2027)
11.1.3. Market Revenue Forecast by End-user (2016-2027)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2016-2027)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2016-2027)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type(2016-2027)
11.2.2. Market Revenue Forecast by Application (2016-2027)
11.2.3. Market Revenue Forecast by End-user (2016-2027)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2016-2027)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2016-2027)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2016-2027)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2016-2027)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2016-2027)
11.3.2. Market Revenue Forecast by Application (2016-2027)
11.3.3. Market Revenue Forecast by End-user (2016-2027)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2016-2027)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2016-2027)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2016-2027)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type(2016-2027)
11.4.2. Market Revenue Forecast by Application (2016-2027)
11.4.3. Market Revenue Forecast by End-user (2016-2027)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2016-2027)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2016-2027)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2016-2027)
11.5.2. Market Revenue Forecast by Application (2016-2027)
11.5.3. Market Revenue Forecast by End-user (2016-2027)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2016-2027)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2016-2027)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2016-2027)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2016-2027)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. Illumina, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Oxford Nanopore Technologies
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. QIAGEN N.V.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. BGI
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Eurofins Scientific
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. GE Healthcare
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Agilent Technologies, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Bio-Rad Laboratories, Inc.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. F. Hoffmann-La Roche Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Get Full Access of this Research Report, Click here@ https://www.precedenceresearch.com/checkout/1204
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
